Profound degeneration of wake-promoting neurons in Alzheimer's disease

Sleep-wake disturbances are a common and early feature in Alzheimer's disease (AD). The impact of early tau pathology in wake-promoting neurons (WPNs) remains unclear. We performed stereology in postmortem brains from AD individuals and healthy controls to identify quantitative differences in m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alzheimer's & dementia 2019-10, Vol.15 (10), p.1253-1263
Hauptverfasser: Oh, Jun, Eser, Rana A., Ehrenberg, Alexander J., Morales, Dulce, Petersen, Cathrine, Kudlacek, Jessica, Dunlop, Sara R., Theofilas, Panos, Resende, Elisa D.P.F., Cosme, Celica, Alho, Eduardo J.L., Spina, Salvatore, Walsh, Christine M., Miller, Bruce L., Seeley, William W., Bittencourt, Jackson C., Neylan, Thomas C., Heinsen, Helmut, Grinberg, Lea T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Sleep-wake disturbances are a common and early feature in Alzheimer's disease (AD). The impact of early tau pathology in wake-promoting neurons (WPNs) remains unclear. We performed stereology in postmortem brains from AD individuals and healthy controls to identify quantitative differences in morphological metrics in WPNs. Progressive supranuclear palsy (PSP) and corticobasal degeneration were included as disease-specific controls. The three nuclei studied accumulate considerable amounts of tau inclusions and showed a decrease in neurotransmitter-synthetizing neurons in AD, PSP, and corticobasal degeneration. However, substantial neuronal loss was exclusively found in AD. WPNs are extremely vulnerable to AD but not to 4 repeat tauopathies. Considering that WPNs are involved early in AD, such degeneration should be included in the models explaining sleep-wake disturbances in AD and considered when designing a clinical intervention. Sparing of WPNs in PSP, a condition featuring hyperinsomnia, suggest that interventions to suppress the arousal system may benefit patients with PSP.
ISSN:1552-5260
1552-5279
DOI:10.1016/j.jalz.2019.06.3916